....COMMERCIALIZATION……….STEM Hires Former Elan Pharmaceuticals Executive Vice President
Nice to see a serious development guy from a significant pharma company, believing in STEM and signing on exclusively. STEM has the research, the next step is the development, glad to see them moving right along! This is a very exciting time for STEM.
STEM may see $2 again before $3, but IMO it will see $8-14/share before 2014 is over, unless they get bought out before then (actually I hope it doesn't get bought out, if it's only for $4-5/share). Obviously the share price will have its ups and downs on the way, wherever it ultimately goes.